Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $1.25M in the quarter ending March 31, 2024, a decrease of -38.87%. This brings the company's revenue in the last twelve months to $7.29M, down -19.67% year-over-year. In the year 2023, Janux Therapeutics had annual revenue of $8.08M, down -6.14%.

• Revenue (ttm): $7.29M
• Revenue Growth: -19.67%
• P/S Ratio: 313.01
• Revenue / Employee: $113,859
• Employees: 64
• Market Cap: 2.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	8.08M	-529.00K	-6.14%
Dec 31, 2022	8.61M	4.98M	136.79%
Dec 31, 2021	3.64M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.